STOCKHOLDERS' EQUITY (Details 1) - Common Stock Restricted Stock Awards (RSA) - $ / shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Non-vested, beginning of period | 140,221 | |
| Granted | 38,378 | 445,490 |
| Vested | (178,599) | (295,861) |
| Non-vested as of end of the period | 149,629 | |
| Non-vested Weighted average grant date fair value per share beginning | $ 7.96 | $ 0 |
| Weighted average grant date fair value per share, Granted | 21.50 | 7.96 |
| Weighted average grant date fair value per share, Vested | 10.87 | 7.96 |
| Non-vested Weighted average grant date fair value per share ending | $ 0 | $ 7.96 |
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|